Background Automated insulin delivery (AID) systems have been shown to be safe and
effective in reducing hyperglycemia and hypoglycemia but are not universally available …

In this posthoc analysis, we quantify variability of day-today exogenous insulin requirements,
and characteristics associated with higher variability of insulin requirements from a study …

Background Exercise can rapidly drop glucose in people with type 1 diabetes. Ubiquitous
wearable fitness sensors are not integrated into automated insulin delivery (AID) systems …

Understanding how automated insulin delivery (AID) algorithm features impact glucose
control under full closed loop delivery represents a critical step toward reducing patient …

OBJECTIVE To document glycemic and user-initiated bolus changes following transition
from predictive low glucose suspend (PLGS) system to automated insulin delivery (AID) …

Background: Loop is an open-source automated insulin delivery (AID) system, used by more
than 9,000 people with type 1 diabetes. Understanding the pros and cons of Loop use may …

As increasing numbers of people with insulin-managed diabetes use automated insulin
delivery (AID) systems or seek such technologies, healthcare providers are faced with a …

Objectives Diabetes management presents a substantial burden to individuals living with the
condition and their families, healthcare professionals, and healthcare systems. Although an …

Although automated bolus calculators (ABCs) have become a mainstay in insulin pump
therapy, they have not achieved similar levels of adoption by persons with diabetes (PWD) …

Automated insulin delivery (AID) systems play an important role in the management of type 1
diabetes mellitus (T1DM). These systems include three components: a continuous glucose …